Atreca, Inc. - (BCEL) Social Stream

Atreca, Inc. - (BCEL): $1.79

0.00 (0.00%)

POWR Rating

Component Grades













Add BCEL to Watchlist
Sign Up

Industry: Biotech


of 399

in industry

Atreca Inc (BCEL) Price Targets From Analysts

Use the tables below to see what analysts covering Atreca Inc think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2022-01-31 7 $30 $12 $21.333 $3.16 575.09%
2022-02-04 6 $27 $11 $18.166 $3.16 474.87%
2022-03-04 7 $25 $11 $16.833 $3.16 432.69%

The Trend in the Analyst Price Target

Over the past 14 months, BCEL's average price target has gone down $11.58.

BCEL reports an average of 331.01% for its upside potential over the past 48 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-04-10 5 35 25 30.22 12.29 145.89%
2021-09-11 5 35 12 21.67 6.13 253.51%
2021-09-18 5 35 12 21.67 6.29 244.52%
2021-09-19 5 35 12 21.67 6.29 244.52%
2021-09-20 5 35 12 21.67 6.44 236.49%

BCEL Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 7 0 0 0 0 7

The Trend in the Broker Recommendations

Over the past 151 days, BCEL's average broker recommendation rating improved by 0.5.

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • To contextualize these metrics, consider that out of all US stocks, Atreca Inc's upside potential (average analyst target price relative to current price) is higher than 480.85% of them.
  • In terms of how Atreca Inc fares relative to all US stocks, note that its variance in analysts' estimates is lower than -343.34% of that group.
  • To contextualize these metrics, consider that out of stocks in the small market cap category, Atreca Inc's number of analysts covering the stock is greater than 401.41% of them.
  • Atreca Inc's average analyst price target is higher than 152.82% of Healthcare stocks.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to Atreca Inc are AVTE, AVEO, and AVDL.

Is BCEL a Buy, Hold or Sell? See the POWR Ratings now!

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.4451 seconds.